Thus, our results revealed a previously unknown oncogenic function of miR-150 in NSCLC by modulating autophagy and provided the evidence that c-myc/miR-150/EPG5 axis could be a potential therapeutic target in the clinical setting. Here, MYC is linked to non-small cell lung carcinoma.